GHK-Cu Copper Peptide: Compound Profile and Chemistry
A chemical profile of GHK-Cu, the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine: how the copper is bound, the 1:1 and 2:1 forms, the names in use, bench handling and regulation.
CATALOGUE / GHK-CU
Research peptide · Lyophilised powder in a sealed vial · for laboratory and research use only
| CAS number | 89030-95-5 (prezatide copper); 49557-75-7 (GHK) |
|---|---|
| Molecular weight | 402.92 g/mol (1:1 complex as recorded); 340.38 g/mol (free GHK); PubChem reference values |
| Storage | Sealed, dry and dark at −20 °C or colder; −50 to −80 °C for long-term storage |
| Certificate of analysis | Available on request · Request a COA |
CAS number and molecular weight are reference values for the compound identity, from PubChem. PubChem holds records for both 1:1 and 2:1 peptide-to-copper forms.
| Compound class | Copper(II)–tripeptide complex |
|---|---|
| Sequence (one-letter) | GHK (Gly-His-Lys), complexed with Cu(II) |
| Molecular formula | C14H23CuN6O4+ (1:1 complex as recorded by PubChem, prezatide copper); C14H24N6O4 (free GHK) |
| PubChem CID | 71587328 (prezatide copper); 73587 (GHK) |
| Other names | Copper tripeptide-1, prezatide copper, GHK copper |
| Supplied as | Lyophilised powder, sealed vial |
| Quantity per vial | 50 mg |
| Intended use | Laboratory and research use only |
GHK-Cu is the copper(II) complex of GHK (glycyl-L-histidyl-L-lysine), a tripeptide first reported in human plasma in 1973 that binds copper(II) strongly.1 It is also known as copper tripeptide-1 and, as a nonproprietary name, prezatide copper.2
Titan Peptides supplies GHK-Cu as a lyophilised powder in a sealed 50 mg vial, for laboratory and research use only. It is a research chemical: not a drug, food or cosmetic, and not for human consumption.
GHK-Cu is not named in the Poisons Standard June 2026 (F2026L00633). The instrument does contain a general Schedule 4 entry for "copper compounds for human use", with exceptions that include preparations containing 5% or less of copper compounds.3 The TGA's 13 April 2026 safety advisory names GHK-Cu as an example of an unapproved peptide product, not evaluated by the TGA for safety, quality or effectiveness, and states that a "research use only" disclaimer does not make supply lawful.4
The GHK-Cu sold here is a research chemical, not an approved therapeutic good. See research peptides and Australian law.
Store the sealed vial dry, dark and frozen at −20 °C or colder, and let it reach room temperature in a desiccator before opening. The copper centre adds two bench considerations: the complex exists as several species depending on pH, so buffer choice can change what is actually in solution, and its blue colour can interfere with absorbance-based or colorimetric assays. PubChem holds records for both 1:1 and 2:1 peptide-to-copper forms, so confirm which form a document describes before comparing its formula or mass with a record. Keep solutions short-lived, in single-use frozen aliquots. See how to store peptides and reconstituting peptides with bacteriostatic or sterile water for the reasoning behind each step.
GHK-Cu is supplied as a lyophilised powder in a sealed vial containing 50 mg, for laboratory and research use only. Solutions of the complex are blue, the usual colour of copper(II) compounds of this type. Because PubChem records 1:1 and 2:1 peptide-to-copper forms with different formulas and masses, the stated form and any counter-ion matter when reading documentation.
PubChem lists prezatide copper, the 1:1 copper complex also called copper tripeptide-1, under CAS 89030-95-5 and CID 71587328, with formula C14H23CuN6O4+ and molar mass 402.92 g/mol as recorded. Free GHK, the tripeptide without copper, has CAS 49557-75-7 and CID 73587, formula C14H24N6O4 and molar mass 340.38 g/mol.
No. AHK-Cu is L-alanyl-L-histidyl-L-lysine bound to copper, a different complex with a different formula and mass. Check the sequence a document or study used rather than the label 'copper peptide'.
GHK-Cu is not named in the June 2026 Poisons Standard, which does contain a general Schedule 4 entry for copper compounds for human use. The TGA lists GHK-Cu among its examples of unapproved peptide products and says a research-use-only label does not make supply lawful. The GHK-Cu sold here is a research chemical, not an approved therapeutic good.
A chemical profile of GHK-Cu, the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine: how the copper is bound, the 1:1 and 2:1 forms, the names in use, bench handling and regulation.